Protective effect of suberoylanilide hydroxamic acid against lps-induced septic shock in rodents

Shock

Volumn 32, Issue 5, 2009, Pages 517-523

  Li, Yongqing ^a   Liu, Baoling ^a   Zhao, Hang ^b   Sailhamer, Elizabeth A ^a   Fukudome, Eugene Y ^a   Zhang, Xiaobo ^c   Kheirbek, Tareq ^a   Finkelstein, Robert A ^a,d   Velmahos, George C ^a   Demoya, Marc ^a   Hales, Charles A ^b   Alam, Hasan B ^a,d  

^a Division of Trauma   (United States)

^b Pulmonary and Critical Care Unit   (United States)

^c Department of Surgery ^*

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acetylation; Histone; LPS; Lung; Macrophage; Septic shock; Suberoylanilide hydroxamic acid; Survival

Indexed keywords

HISTONE H2A; HISTONE H2B; HISTONE H3; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VORINOSTAT;

ACETYLATION; ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; GENE EXPRESSION; GRANULOCYTE; HISTOPATHOLOGY; INFLAMMATION; LUNG INJURY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SEPTIC SHOCK; SURVIVAL RATE;

ACETYLATION; ACUTE LUNG INJURY; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; HISTONE DEACETYLASE INHIBITORS; HISTONES; HYDROXAMIC ACIDS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350241806     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181a44c79     Document Type: Article

References (30)

1. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235-243, 1997.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
3. Coimbra R, Melbostad H, Loomis W, Porcides RD, Wolf P, Tobar M, Hoyt DB: LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. J Trauma 60:115-125, 2006.
4. Zhang HQ, Wang HD, Lu DX, Qi RB, Wang YP, Yan YX, Fu YM: Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. Shock 29:617-622, 2008.
5. Takemura R, Werb Z: Secretory products of macrophages and their physiological functions. Am J Physiol 246:C1YC9, 1984.
6. Leoni FZA, Bertolini G, Porro G, Pagani P, Pozzi P, Donà G, Fossati G, Sozzani S, Azam T, Bufler P, et al.: The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci U S A 99:2995-3000, 2002.
7. Lai ZW, Hundeiker C, Gleichmann E, Esser C: Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 52: 30-37, 1997.
8. Butler LM, Aqus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60:5165-5170, 2000.
9. Beutler B, Cerami A: The biology of cachectin/TNFVa primary mediator of the host response. Annu Rev Immunol 7:625-655, 1989.
10. Old L: Tumor necrosis factor (TNF). Science 230:630-632, 1985.
11. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ 3rd, Zentella A, Albert JD, et al.: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
12. Fein AM, Calalang-Colucci MG: Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 16:289-317, 2000.
13. Lukacs NW, Strieter RM, Chensue SW, Widmer M, Kunkel SL: TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 154:5411-5417, 1995.
14. Springer TA: Leucocyte adhesion to cells. Scand J Immunol 32:211-216, 1990.
15. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL: Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax 48:765-769, 1993.
16. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene WintercrineW cytokine family. Annu Rev Immunol 9:617-648, 1991.
17. Lin T, Chen H, Koustova E, Sailhamer EA, Li Y, Shults C, Liu B, Rhee P, Kirkpatrick J, Alam HB: Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. Surgery 141:784-794, 2007.
18. Alam HB, Shults C, Ahuja N, Ayuste EC, Chen H, Koustova E, Sailhamer EA, Li Y, Liu B, de Moya M, et al.: Impact of resuscitation strategies on the acetylation status of cardiac histones in a swine model of hemorrhage. Resuscitation 76:299-310, 2008.
19. Gonzales E, Chen H, Munuve R, Mehrani T, Britten-Webb J, Nadel A, Alam HB, Wherry D, Burris D, Koustova E: Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones. Shock 25:395-401, 2006.
20. Sailhamer EA, Li Y, Smith EJ, Shuja F, Shults C, Liu B, Soupir C, deMoya M, Velmahos G, Alam HB: Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 144:204-216, 2008.
21. HocklyE, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PAS, et al.: Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 100:2041-2046, 2003.
22. Saha RN, Pahan K: HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13:539-550, 2006.
23. Hamon MA, Batsche E, Regnault B, Tham TN, Seveau S, Muchardt C, Cossart P: Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci U S A 104:13467-13472, 2007.
24. Dinarello CA: Inhibition of histone deacetylases as anti-inflammatory drugs. Ernst Schering Res Found Workshop 56:45-60, 2006.
25. Li Y, Yuan Z, Liu B, Sailhamer EA, Shults C, Velmahos GC, deMoya M, Alam HB: Prevention of hypoxia-induced apoptosis through histone deacety-lase inhibition. J Trauma 64:863-870, 2008.
26. Bode KA, Schroder K, Hume DA, Ravasi T, Heeg K, Sweet MJ, Dalpke AH: Histone deacetylase inhibitors decrease Toll-like receptorYmediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology 122:596-606, 2007.
27. Cao W, Bao C, Padalko E, Lowenstein CJ: Acetylation of mitogen-activated protein kinase phosphataseY1 inhibits Toll-like receptor signaling. J Exp Med 205:1491-1503, 2008.
28. Li Y, Liu B, Sailhamer EA, Yuan Z, Shults C, Velmahos GC, deMoya M, Shuja F, Butt MU, Alam HB: Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery 144:217-224, 2008.
29. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, Lang R: Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 203:15-20, 2006.
30. Shults C, Sailhamer E, Li Y, Liu B, Tabbara M, Butt MU, Shuja F, deMoya M, Velmahos GC, Alam HB: Surviving blood loss without fluid resuscitation. J Trauma 64:629-640, 2008.